Oregon Voters Block Psilocybin Businesses

November 11, 2024

Lykos, FDA Discuss Phase 3 MDMA Trial Plans

October 20, 2024

Study: Psilocybin Boosts Optimism

October 10, 2024

SEC Charges Phony Psilocybin Company

October 10, 2024

Study: Millions Could Benefit From Psilocybin-Assisted Therapy

September 19, 2024

Study: Low-Dose Ketamine Could Reduce Fentanyl Withdrawal Symptoms

September 19, 2024